FABBS reports on items of interest to many communities – scientists, policymakers, and the public. In our news, you will see updates on science funding and policy, articles that translate research for policy, and descriptions of the research contributions of scientists at all stages of their research careers.
Feldman Barrett Highlights Need to Integrate Neuroscience and Behavioral Science
April 20th, 2017
At a Friday morning meeting of behavioral and social science representatives at NIH, Dr. Lisa Feldman Barrett, Northeastern University, called for a greater integration of neuroscience with behavioral science as well as the need for a cumulative science to advance research and knowledge. Feldman Barrett addressed the NIH’s Behavioral and Social Sciences Research Coordinating Committee, a group of behavioral and social scientists selected by each of the NIH Institute and
read moreFABBS Welcomes New Member: Society for the Scientific Study of Reading
April 20th, 2017
The FABBS Board is pleased to welcome the Society for the Scientific Study of Reading (SSSR) as a new member scientific society. SSSR joins numerous other scientific societies that share an interest in advancing the sciences of mind, brain, and behavior.
SSSR’s purpose is to promote the scientific study of reading and to share information about reading, language, and literacy with the public. The Society was formed in 1993, and currently has 526 members,
read moreAn ounce of prevention for depression and anxiety
April 20th, 2017
A shocking third of Americans have been affected by clinical depression or anxiety in their lifetimes. That high number suggests that mood disorders, which were once thought of as personal problems, may be more accurately thought of as societal problems. Indeed, social and economic trends like the recession of 2008 are correlated with the prevalence of depression. And the implications are societal as well; depression cost the American economy over $200 billion in a
read moreFor Early Detection of Alzheimer’s Disease, Listen to Patients
April 20th, 2017
Early identification of disease often makes treatment easier and more successful. In recent years, scientists have developed a wide array of tests that use gene sequencing and other biomarkers to improve early detection of many diseases. These efforts are valuable, but often complex and expensive. Neuropsychologist Rebecca Amariglio has been focusing on a more straightforward and often overlooked strategy: asking patients whether they notice early symptoms of disease.
read more